DUTKO WORLDWIDE, LLC for GLAXOSMITHKLINE
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| DARREN WILLCOX | — |
Health Issues HCR
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.